Publications by authors named "B J Lund"
Periacetabular osteotomy (PAO) is the treatment of choice in dysplastic acetabulum. Due to continued symptoms, 2-11% of these patients require an additional hip arthroscopy. The purpose of this study was to report clinical outcome after a minimum of 2-year follow-up of additional hip arthroscopy after PAO with data from Danish Hip Arthroscopy Registry.
View Article and Find Full Text PDFPatients with opioid use disorder (OUD) represent a high-risk population due to increased rates of adverse health outcomes and death. To evaluate whether telehealth utilization during OUD treatment compared with in-person encounters alone was associated with emergency department (ED) utilization, inpatient admissions, and mortality within three years of initiating buprenorphine. We conducted a retrospective cohort study within the Veterans Health Administration among Veterans treated for OUD between 2012 and -2022.
View Article and Find Full Text PDFArticle Synopsis
- The study investigates the impact of 3D-printed polycaprolactone (PCL) scaffolds with varying stiffness and porosity on bone tissue engineering and the immune response involved in bone regeneration.
- PCL scaffolds were produced using different techniques, revealing that high-temperature printing creates stiffer structures while low-temperature printing with NIPS results in more flexible, porous scaffolds.
- Results indicated that porosity and stiffness of the scaffolds influence not only the proliferation and mineralization of bone marrow-derived stem cells but also the activation of immune cells, suggesting a complex relationship between scaffold properties and biological responses.
Disclaimer: In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.
View Article and Find Full Text PDFBackground: Evidence concerning tolerability of sodium-glucose co-transporter-2 (SGLT2) inhibitors in older adults is limited due to under-representation in clinical trials. Our study aimed to determine the extent to which SGLT2 inhibitor intolerance increases with age and explore additional factors associated with intolerance.
Methods: This retrospective observational study included patients in the Veterans Health Administration who initiated an SGLT2 inhibitor between 1 January 2013 and 31 December 2021.